Urolution Medical manufactures the OpenFlo™ Indwelling Urinary Catheter, designed to enhance patient comfort and reduce the risk of urinary tract infections. This catheter features a streamlined design that minimizes friction and promotes better drainage, addressing common complications associated with traditional catheters.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional indwelling urinary catheters can cause discomfort, friction, and inadequate drainage, increasing the risk of urinary tract infections (UTIs) and other complications for patients. These issues can lead to extended hospital stays, increased healthcare costs, and reduced patient quality of life.
Solution
Urolution Medical's OpenFlo™ Indwelling Urinary Catheter is engineered to improve patient comfort and reduce the incidence of catheter-associated urinary tract infections (CAUTIs). The catheter's design minimizes friction during insertion and use, promoting enhanced drainage and reducing the risk of blockage. By addressing common issues associated with traditional catheters, the OpenFlo™ aims to improve patient outcomes and lower healthcare costs related to catheter-related complications.
Target Audience
The primary target audience includes hospitals, long-term care facilities, and individual patients requiring indwelling urinary catheters.
Features
- Streamlined design to minimize friction during insertion and while indwelling.
- Enhanced drainage capabilities to reduce the risk of catheter blockage.
- Materials selected for biocompatibility and reduced encrustation.